PDZ domain-containing scaffold protein Par-3 is the central organizer of the evolutionarily conserved cell polarity-regulatory Par-3⅐Par-6⅐atypical protein kinase C complex. The PDZ domains of Par-3 have also been implicated as potential phosphoinositide signaling integrators, since its second PDZ domain binds to phosphoinositides, and the third PDZ interacts with phosphoinositide phosphatase PTEN. However, the molecular basis of Par-3/PTEN interaction is still poorly understood. Additionally, it is not known whether the regulatory function of PTEN in cell polarity is specifically mediated by its interaction with Par-3. The structures of Par-3 PDZ3 in both its free and PTEN tail peptide-bound forms determined in this work reveal that Par-3 PDZ3 binds to PTEN with two discrete binding sites: a canonical PDZ-ligand interaction site and a distal, opposite charge-charge interaction site. This distinct target recognition mechanism confers the interaction specificity of the Par-3⅐PTEN complex. We show that the Par-3 PDZ3-PTEN binding is required for the enrichment of PTEN at the junctional membranes of Madin-Darby canine kidney cells. Finally, we demonstrate that the junctional membrane-localized PTEN is specifically required for the polarization of Madin-Darby canine kidney cells. These results, together with earlier data, firmly establish that Par-3 functions as a scaffold in integrating phosphoinositide signaling events during cellular polarization.
Here, we have determined the solution structure of Par-3 PDZ3 alone and in complex with the PTEN C-terminal tail peptide by NMR spectroscopy. We discovered that the interaction between Par-3 PDZ3 and the PTEN tail peptide is distinct from all known canonical PDZ-target complexes. We further showed that the junctional membrane localization of PTEN depends on this specific Par-3 PDZ3-PTEN tail peptide interaction. Finally, our data demonstrate that Par-3 PDZ3-mediated PTEN localization to the membrane junctions is essential for the polarization of MDCK cells.
EXPERIMENTAL PROCEDURES
Protein Purification and Antibodies-The coding sequence for Par-3 PDZ3 (residues 579 -704) was PCR-amplified from the full-length rat Par-3 (ASIP) and cloned into a modified pET32a vector. Rat PTEN construct was described in our earlier work (25) . All point mutants of Par-3 and PTEN were prepared using the PCR-based method. Par-3 PDZ3-PTEN peptide fusion protein contained a thrombin cleavage site (LVPRGS) between the C terminus of PDZ3 and the PTEN peptide (DEDQSHQITKV).
Proteins were expressed in BL21 (DE3) Escherichia coli cells at either 37 or 16°C. The His 6 -tagged PDZ proteins were purified by Ni 2ϩ -nitrilotriacetic acid-agarose (Qiagen) affinity chromatography followed by size exclusion chromatography. Uniformly isotope-labeled PDZ3 samples were prepared by growing bacteria in M9 minimal medium using 15 NH 4 Cl as the sole nitrogen source or 15 NH 4 Cl and 13 C 6 -glucose as the sole nitrogen and carbon sources, respectively. For in vitro GST pull-down-based assays, GST-PDZ3, GST-PTEN peptide, and their respective mutants were individually cloned into pGEX-4T-1 vector. The fusion proteins were purified by GlutathioneSepharose-4B affinity chromatography (Amersham Biosciences). Myc9E10 monoclonal antibody was purchased from DSHB, anti-GFP antibody was from Invitrogen, and anti-PTEN polyclonal antibody and anti-rabbit horseradish peroxidaseconjugated secondary antibody were from Cell Signaling.
NMR Spectroscopy-The NMR samples were concentrated to ϳ0.1 mM (for titration experiments) or ϳ1 mM (for structural determinations) in 20 mM phosphate buffer, pH 6.0, 1 mM dithiothreitol, and 1 mM EDTA. NMR spectra were acquired at 30°C on Varian Inova 500 or 750 MHz spectrometers, each equipped with a z-axis shielded triple resonance probehead. Sequential backbone and nonaromatic, nonexchangeable side chain resonance assignments of Par-3 PDZ3 alone and in complex with the PTEN peptide were achieved by standard heteronuclear correlation experiments, including HNCO, HNCACB, CBCA(CO)NH, and HCCH-TOCSY, using 15 N/ 13 C-labeled samples, and confirmed by a three-dimensional 15 N-separated NOESY experiment using 15 Nlabeled samples (32, 33) . Except for the residues in the tag region, 100% backbone sequential resonance assignments were completed, and more than 98% nonaromatic side chain resonance assignments were obtained. The side chains of aromatics were further assigned by 1 H two-dimensional TOCSY and NOESY experiments using unlabeled samples in D 2 O (34).
Structure Calculations-Approximate interproton distance restraints were derived from two-dimensional 1 H NOESY, threedimensional 15 N-seperated NOESY, and three-dimensional 13 Cseperated NOESY spectra. NOE restraints were grouped into three distance ranges: 1.8 -2.7 Å (1.8 -2.9 Å for NOEs involving NH protons), 1.8 -3.3 Å (1.8 -3.5 Å for NOEs involving NH protons), and 1.8 -5.0 Å, corresponding to strong, medium, and weak NOEs, respectively. Hydrogen bonding restraints were generated from the standard secondary structure of the protein based on the NOE patterns and backbone secondary chemical shifts. Backbone dihedral angle restraints ( and angles) were derived from the secondary structure of the protein and backbone chemical shift analysis program TALOS (35) . Structures were calculated using the program CNS (36) .
In Vitro Pull-down Assay-Aliquots of 50 l of GST or GSTtagged proteins from 1 mg/ml stock solutions were first loaded to 20 l of glutathione-Sepharose 4B slurry beads in an assay buffer containing 50 mM Tris-HCl, pH 7.5, 100 mM NaCl, and 1 mM dithiothreitol for 1 h at 4°C. The GST fusion proteinloaded beads were washed twice with the assay buffer and then mixed with potential binding partners (purified recombinant proteins or HEK293T cell lysates overexpressed with GFPtagged target proteins), and the mixtures were then incubated for 2 h at 4°C. Beads were then washed three times each with 500 l of the assay buffer. The proteins captured by the affinity beads were eluted by boiling, resolved by 15% SDS-PAGE, and detected either by Coomassie Blue staining or by immunoblotting with specific antibodies. In the pull-down assays, HEK293T cells transiently transfected with GFP-tagged proteins were lysed using radioimmune precipitation buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% Nonidet P-40, 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride).
Fluorescence Polarization Assay-Fluorescence polarization assays were performed on a PerkinElmer Life Sciences LS-55 fluorimeter equipped with an automated polarizer at 20°C. The PTEN synthetic peptide was labeled with fluorescein-5-isothiocyanate (Molecular Probes) at its N terminus. Fluorescence titration was performed by adding increasing amounts of Par-3 PDZ3 or its mutants to a constant amount of the fluorescein-5-isothiocyanate-PTEN peptide (ϳ1 M) in 50 mM HEPES buffer (pH 7.4) containing 100 mM NaCl, 1 mM EDTA, and 1 mM dithiothreitol. The dissociation constants (K d ) were obtained by fitting the titration curves with the classical onesite binding model using the software GraphPad. In this assay, ⌬mP ϭ mP Ϫ mP 0 , where mP is the measured polarization value of each titration point, and mP 0 is the polarization value of the free peptide.
RNA Interference and PTEN Knockdown-The sequences of the oligonucleotides used to knock down canine PTEN were designed using Dharmacon's online siDesign Center and inserted into pSUPER vector. Annealed double strand oligonucleotides were inserted into the BglII and HindIII cloning sites of the pSUPER vector. The two pairs of canine PTEN shRNA were designed as follows: sense primer for pSPTEN1, 5Ј-gatccccCAGATAATGACAAGGAATATTCAAGAGATATTCCTTGTCATTATCTGtttttggaaa-3Ј; antisense primer for pSPTEN1, 5Ј-agcttttccaaaaaCAGATAATGACAAGGAATATCTCTTGAATATTCCTTGTCATTATCTGggg-3Ј; sense primer for pSPTEN2, 5Ј-gatccccAGTAAGGACCAGAGACAAATTCAAGAGATTTGTCTCTTGGTCCTTACTtttttggaaa-3Ј; pSPTEN2 antisense primer, 5Ј-agcttttccaaaaaAGTAAGG-ACCAGAGACAAATCTCTTGAATTTGTCTCTTGGTCCTTACTggg-3Ј. Italic type indicates the 9-bp hairpin loop, and letters in lowercase represent the sequence designed for creating BglII and HindIII restriction digestion sites. Par-3-specific shRNA was designed as previously reported (25, 37) . The empty pSUPER vector was used as a control for the PTEN knockdown. The following primary antibodies were used in the Western blot to assay the knockdown efficiency of PTEN: anti-PTEN polyclonal antibody (1:1000) (Cell Signaling), anti-occludin polyclonal antibody (1:1000) (Zymed Laboratories Inc.), and anti-␤-tubulin monoclonal antibody (1:1000) (DSHB). Horseradish peroxidase-conjugated donkey anti-mouse (Jackson Laboratories) or donkey anti-rabbit secondary antibodies (Cell Signaling) were used at a concentration of 1:10000.
Cellular Localization and Stable Cell Line-The wild type Par-3 was cloned into the pEGFP-C2 vector, and the wild type PTEN was cloned into the pCMV-Myc vector. MDCK II cells were transiently co-transfected with 0.5 g each of PTEN and Par-3 plasmids/well using the Lipofectamine TM PLUS kit (Invitrogen) and cultured for 48 h before fixation. HEK293T cells or MDCK II cells were cultured at 37°C in minimal essential medium supplemented with 10% fetal bovine serum under a humidified atmosphere of 5% CO 2 . MDCK cells stably expressing GFP-PLC␦ PH were generated by selecting transfected cells with 500 g/ml G418 as selection marker, and positive clones were maintained in normal cultural medium containing 250 g/ml G418.
Calcium Switch Assay-Calcium switch experiments were performed as described previously (25) . Briefly, pSPTEN1 was delivered using nucleotransfection kit (Amaxa) into cultured MDCK II cells with or without stably expressing GFP-PLC␦ PH, along with the wild type PTEN or its mutants. After electroporation, ϳ7.5 ϫ 10 5 MDCK II cells were seeded in a 24-well tissue culture plate with minimal essential medium containing 1.8 mM calcium (high calcium medium). After ϳ40 h of incubation, a confluent monolayer of MDCK cells was formed. Cells were washed twice with phosphate-buffered saline and incubated in minimal essential medium supplemented with 2% calf serum, which was dialyzed against 150 mM NaCl overnight (low calcium medium). After a 16-h incubation in low calcium medium, cells were switched back to HCM for the indicated time durations. To detect ZO-1, cells were washed then fixed in 4% paraformaldehyde for 15 min at room temperature and permeabilized with 0.2% Triton X-100 in phosphate-buffered saline. After washing with phosphate-buffered saline, cells were blocked with 10% normal donkey serum in phosphate-buffered saline for 1 h and incubated with anti-ZO-1 primary antibody and Red X-conjugated secondary antibody (anti-rabbit; Jackson Laboratory). The images were acquired and analyzed using a Nikon TE2000E inverted fluorescent microscope. Images were taken using a monochrome camera detection system, and composite pseudocolors are used in the merged figures for comparison. 
RESULTS AND DISCUSSION
Overall Structure of Par-3 PDZ3-As the first step in elucidating the molecular basis of the Par-3/PTEN interaction, we determined the solution structure of the ligand-free form of Par-3 PDZ3 using NMR spectroscopy. Except for a few residues in the two termini, the overall structure of Par-3 PDZ3 is well defined ( Fig. 1A and Table 1 ). Par-3 PDZ3 adopts the canonical PDZ domain fold composed of six ␤-strands and two ␣-helices, of which the six ␤-strands form a partially open barrel with each of the open ends capped with an ␣-helix (Fig. 1B) . Uniquely, the ␣B helix of Par-3 PDZ3 is one turn longer than the corresponding helix in the canonical PDZ domains (Fig. 1B) . Parallel to the elongation of the ␣B helix, both ␤B and ␤C of Par-3 PDZ3 are longer than the corresponding ␤-strands in most PDZ domains. Therefore, the peptide ligand-binding channel of Par-3 PDZ3 is significantly elongated (Fig. 1B) . Additionally, both the ␤A/␤B-loop and the ␤B/␤C-loop of the ligand-free Par-3 PDZ3 are well structured (Fig. 1A) Fig. 2 ). Amino acid sequence alignment analysis of PTEN from various species revealed that the three residues preceding the extreme carboxyl terminus are highly conserved acidic amino acids (see Fig. 3A ), suggesting that these negatively charged residues might be interacting with the residues in the positively charged surface cluster of Par-3 PDZ3.
To elucidate the detailed interaction mechanism between Par-3 PDZ3 and PTEN, we decided to determine the structure of Par-3 PDZ3 in complex with the PTEN peptide. First, we A, amino acid sequence alignment of the PTEN C-terminal tail across different species. The conserved PDZ domain-binding motif residues are colored in green; the conserved negative charge clustered residues are colored in red. B, the interface between the PTEN peptide and Par-3 PDZ3. Par-3 PDZ3 is shown using surface representation. The hydrophobic residues are drawn in yellow, positively charged residues in blue, negatively charged residues in red, and others in gray. The PTEN peptide is shown with the worm model. The side chains of the residues in PDZ-binding motif and three negatively charged residues ( Ϫ10 DED Ϫ8 ) of the peptide are shown in a stick representation. C and D, salt concentration-dependent interaction between Par-3 PDZ3 and PTEN. C, GST-fused PTEN peptide (DEDQHSQITKV) was used to pull down purified Par-3 PDZ3 dissolved in assay buffer containing 0, 250, and 500 mM NaCl, respectively. Input, represents 10% total PDZ3 used in the assay. Proteins in this assay were visualized with Coomassie Blue staining. D, purified GST-PDZ3 was used to pull down GFP-tagged full-length PTEN expressed in HEK293T cells in the presence of increasing concentrations of NaCl in the assay buffer. PTEN bound to Par-3 PDZ3 was visualized by immunodetection using anti-GFP antibody (immunoblot; IB). The amount of GST-PDZ3 in this assay is indicated with Coomassie Blue (CBB) staining of the protein. The input of GFP-PTEN represents 10% of the total GFP-PTEN used in the assay. E, measurements of the binding affinities between the PTEN peptide and various forms of Par-3 PDZ3 using fluorescence polarization assay. Neutralization of the positively charged residues on PDZ3 (Lys 606 , Lys 609 , Arg 611 , and Lys 622 ) significantly reduced the binding of the domain to the PTEN peptide. F, mutational analysis of the roles of the positively charged residues in Par-3 PDZ3 in binding to PTEN. Synthetic PTEN peptide competes with the GST-fused PTEN peptide in binding to Par-3 PDZ3 in a dose-dependent manner. The panel also shows that mutation of the positively charged residues in Par-3 PDZ3 greatly reduced its binding to the PTEN peptide. The PDZ3-PTEN peptide fusion protein was included as the negative control of the assay, since the ligand binding pocket of Par-3 PDZ3 is completely blocked by the fused PTEN peptide. G, the Ϫ10 DED Ϫ8 motif of PTEN is critical for Par-3 binding. Mutations of the Ϫ10 DED Ϫ8 motif in the full-length PTEN also reduced its binding to GST-PDZ3. The amount of GST-PDZ3 used in the assay (Input) was shown by Ponceau-S staining. Input in F and G represents 25% of the proteins used in the assays. WT, wild type.
validated that the last 10 residues of PTEN are sufficient for binding to Par-3 PDZ3, since further extension of the peptide toward the N terminus did not enhance the binding affinity between Par-3 PDZ3 and PTEN (data not shown). To facilitate the NMR-based structural determination of the Par-3 PDZ3-PTEN peptide complex, we fused the PTEN peptide to the C terminus of Par-3 PDZ3 to generate a single chain fusion protein. This strategy greatly simplified the complex structure determination. The same strategy has been successfully used in determining the structures of a number of other PDZ domains in complex with their respective target peptides (39, 40) . Additionally, the NMR spectrum of Par-3 PDZ3 in complex with the synthetic PTEN peptide and that of the PDZ3-PTEN peptide fusion protein are essentially identical, indicating that the covalent linking of the PTEN peptide to the PDZ domain has minimal perturbation to the structure of the Par-3 PDZ3-PTEN peptide complex (supplemental Fig. 3) .
The structure of the Par-3 PDZ3-PTEN peptide complex was determined to a high resolution ( Fig. 2A and Table 1 ). The structure of PDZ3 in the complex is highly similar to the structure of the ligand free Par-3 PDZ3 (root mean square deviation of 0.9 comparing the backbones of the two structures). The only notable peptide binding-induced conformational change of Par-3 PDZ3 is the rotation of ␣B, since this rotation is necessary to widen the ␣B/␤B-groove in order to accommodate the PTEN peptide (supplemental Fig. 4) . Consistent with our earlier prediction, the three residues at the extreme C terminus of the PTEN peptide form a ␤-strand that pairs in an antiparallel manner with the ␤B of PDZ3. (Fig.  3B) (38) . No specific hydrogen bonding between the side chain of Thr 403 from the PTEN peptide and the residues from the ␣B-helix of Par-3 PDZ3 could be observed. The side chain of Lys 402 (the so-called Ϫ1 residue) from the PTEN peptide also lacks direct contact with Par-3 PDZ3. As a distinct property of the Par-3 PDZ3-PTEN peptide complex, the three negatively charged residues at the N-terminal end of the PTEN peptide ( Ϫ10 DED Ϫ8 ) directly interact with a cluster of positively charged residues (Lys 606 , Arg 609 , Lys 611 , and Lys 622 ) from the ␤B, ␤C, and ␤B/␤C loop of Par-3 PDZ3 (Figs. 1C and 3B ). This unique charge-charge interaction is predicted to enhance the binding affinity and, perhaps more importantly, to provide the binding specificity between Par-3 PDZ3 and PTEN (i.e. the interaction between Par-3 PDZ3 and PTEN requires the presence of both the classical PDZ-binding motif at the extreme tail and the upstream Ϫ10 DED Ϫ8 motif of PTEN). The Charge-Charge Interaction in the Formation of the PDZ3-PTEN Complex-We next tested the role of the chargecharge interaction, shown in Fig. 3B , in the formation of the Par-3 PDZ3-PTEN complex. In a pull-down assay, the binding of GST-fused PTEN peptide to Par-3 PDZ3 weakened when the salt concentration in the assay buffer was increased (Fig. 3C) . Similarly, the interaction between GST-fused Par-3 PDZ3 and the full-length PTEN expressed in HEK293T cells was also salt concentration-dependent (Fig. 3D) . To test that the positively charged residues in the ␤B-, ␤C-, and ␤B/␤C-loop of Par-3 PDZ3 shown in Fig. 3B are required for binding to PTEN, we substituted individual or multiple positively charged residues with neutral Ala and measured the binding of each mutant to the PTEN peptide using fluorescence spectroscopy and affinity pull-down assays (Fig. 3, E and F) . The data clearly demonstrated that these positively charged residues play important roles in promoting the formation of the Par-3 PDZ3-PTEN peptide complex, since substitution of single or multiple positively charged residues significantly decreased the binding of Par-3 PDZ3 to PTEN. The CD spectra of all these charge neutralization mutants are essentially the same as that of the wild type protein, indicating that the weakened PTEN bindings of the mutants were not the artifact of mutation-induced conformation alterations (supplemental Fig. 5 ). Reciprocally, we made point mutations on the PTEN by converting one or multiple negatively charged residues in the Ϫ10 DED Ϫ8 motif to Ala and subsequently assayed the binding of the PTEN mutants to GST-PDZ3 using pull-down experiments. Consistent with our structural analysis, the point mutations of PTEN also showed significantly weakened binding to Par-3 PDZ3 (Fig. 3G) . Taken together, the data shown in Fig. 3 demonstrate that the chargecharge interaction between the positively charged surface cluster of Par-3 PDZ3 and the Ϫ10 DED Ϫ8 motif of PTEN plays an instructive role for the complex formation. The presence of two discrete binding sites (the canonical PDZ-binding site and the distal charge-charge interaction site) seen in the Par-3 PDZ3-PTEN peptide complex is unique when compared with all currently known PDZ-ligand complexes. The formation of the Par-3⅐PTEN complex is thus likely to be specific when compared with other potential PTEN-binding PDZ domain proteins, including MAGI-2, MAGI-3 (41, 42) , and NHERF (43) . Amino acid sequence analysis of the PDZ domains of MAGI-2, MAGI-3, and NHERF indicated that these PDZ domains do not contain the second chargecharge interaction site seen in the Par-3 PDZ3-PTEN complex (results not shown).
Par-3 Enriches PTEN at Junctional Membranes via Its PDZ3
Domain-We next studied the role of the Par-3/PTEN interaction in the regulation of cell polarity. We first compared the cellular localizations of the wild type PTEN with those of Par-3 PDZ3 binding-deficient PTEN in MDCK cells. Consistent with earlier reports (21, 25, 37) , overexpressed GFP-tagged wild type Par-3 is mainly localized at the membrane junctions of MDCK cells (Fig. 4A) . Myc-tagged PTEN, on the other hand, is mainly diffused, with partial enrichment at the membrane junctions (Fig. 4A) . This observation is consistent with the data reported earlier (31, 44) , and is in line with the modest binding affinity observed between Par-3 PDZ3 and PTEN (Fig. 2) and ubiquitous cellular functions of PTEN. The removal of the last 10 residues of PTEN (PTEN⌬C) led to the complete diffusion of PTEN in MDCK cells, presumably due to the disruption of Par-3 PDZ3-mediated PTEN binding (Fig. 4B) . The truncation of the C-terminal 10 residues of PTEN could have a potential caveat, since the truncation may also disrupt PTEN binding to other potential membrane-associated PDZ domain proteins. Since the charge-charge interaction between the Ϫ10 DED Ϫ8 motif of PTEN and the positively charged surface cluster outside the canonical ligand binding groove of Par-3 PDZ3 is unique to the Par-3⅐PTEN complex, mutation of the negatively charged Ϫ10 DED Ϫ8 in PTEN to AAA (DED3A) can be expected to disrupt Par-3/PTEN interaction FIGURE 5. Junctional membrane-localized PTEN is required for epithelial cell polarization. A, knockdown of endogenous canine PTEN with pSUPER-based shRNA. MDCK II cells were transiently transfected with the empty pSUPER vector (control), pSPTEN1, and pSPTEN2, respectively. pSPTEN1 knocked down ϳ65% of the PTEN expression, and pSPTEN2 reduced ϳ50% of the PTEN expression. The figure also shows that PTEN knockdown did not alter the expression level of the tight junction protein occludin. ␤-Tubulin was used as the loading controls. Error bars, S.D. of three different experiments. B, rescue of the polarization defects of MDCK cells induced by PTEN knockdown with various RNA interference-resistant rat PTEN constructs. MDCK cells were transfected with pSUPER vector, pSPar-3, and pSPTEN1 together with various rescue constructs as indicated. Cells were subjected to the "calcium switch" assay and fixed at the indicated time points after the calcium switch (0, 1, and 4 h). 4Ј,6-diamidino-2-phenylindole (blue) was used to stain nuclei and served for counting the cell numbers in each assay, and ZO-1 (red) was used to monitor the tight junction formation. specifically while leaving other potential PTEN/PDZ interaction intact. In MDCK cells, the DED3A mutant of PTEN is also largely diffused (Fig. 4C) , indicating that the specific Par-3 PDZ3-PTEN interaction is responsible for the enrichment of PTEN in membrane junctions. Based on the above data, one can predict that the disruption of Par-3 junctional membrane localization should also disrupt the membrane enrichment of PTEN. We earlier reported that the disruption of either PDZ2-mediated lipid membrane interaction or NTD-mediated oligomerization of Par-3 led to the complete diffusion of the protein in MDCK cells (21, 25) . When co-expressed with either of these two Par-3 mutants, PTEN is completely diffused in the cytosol (Fig. 4, D and E) . In summary, the above data demonstrate that the partial membrane localization of PTEN requires the Par-3 PDZ3-PTEN interaction.
Par-3 PDZ3-PTEN Interaction Is Required for Epithelial
Cell Polarity-We next tested the role of the Par-3 PDZ3-mediated junctional membrane localization of PTEN in the polarization of MDCK cells. The disruption of Par-3 PDZ3-PTEN interaction was predicted to interfere with the polarization of MDCK cells if the junctional population of PTEN is functionally important. To test this hypothesis, we first knocked down the endogenous PTEN using the RNA interference approach and then compared the capacities of various PTEN mutants in rescuing the function of the wild type PTEN using a "calcium switch"-based MDCK cell repolarization assay. The two shRNAs against PTEN, pSPTEN1, and pSPTEN2 showed specific knockdown of endogenous canine PTEN (Fig. 5A ). Since the pSPTEN1 was somewhat more effective in knocking down the wild type PTEN, this shRNA was used for the subsequent MDCK repolarization assay. In normal calcium-containing medium, MDCK cells transfected with shRNA specific to PTEN (PTEN KD ) will eventually fully polarize (e.g. 48 h after transfection) as indicated by ZO-1 staining (Fig. 5B, HCM) . However, knockdown of PTEN significantly delayed repolarization of MDCK cells after the "calcium switch." This repolarization defect caused by the reduced expression of PTEN was phenotypically copied by knockdown of Par-3, consistent with our biochemical data showing that Par-3 is responsible for bringing PTEN to the junctional membranes (Fig. 5B) . As expected, the expression of small interfering RNA-resistant human PTEN fully rescued the repolarization defect of MDCK induced by the RNA interference knockdown of endogenous PTEN (Fig. 5, B and C) . In contrast, neither PTEN(⌬C) nor PTEN("DED3A") could rescue the repolarization defect of MDCK cells (Fig. 5, B and C) .
We next used the PH domain from PLC␦ as a PI(4,5)P2 biosensor to monitor the junctional membrane PI(4,5)P2. In MDCK cells stably expressing GFP-PLC␦ PH, the colocalization of PLC␦ PH with tight junction marker protein ZO-1 suggested that PI(4,5)P2 is highly enriched at the junctional membrane region in polarized MDCK cells (Fig. 6A, HCM) . Reduced expression of endogenous PTEN by shRNA had a limited effect on both tight junction formation and PI(4,5)P2 junctional membrane enrichment in normal medium (Fig. 6B) , presumably due to the limited knockdown of the phosphatase activity. In the "calcium switch" assay, depletion of Ca 2ϩ not only caused the dissolution of ZO-1 but also disrupted the defined PI(4,5)P2 junctional localization (Fig. 6, C-F) . Expression of the shRNAresistant wild type PTEN fully rescued the junctional enrichment defects of PI(4,5)P2 and the delayed repolarization of MDCK cells induced by the knockdown of the endogenous PTEN (Fig. 6D) . In contrast, PTEN(⌬C) and PTEN(DED3A) failed to restore the junctional localization of PI(4,5)P2 (Fig. 6, E  and F) .
Taken together, the above data strongly support our conclusion that the Par-3 PDZ3-mediated PTEN junctional membrane localization is important in the regulation of epithelial cell polarization. Our study also supports our earlier model that the PDZ3-mediated PTEN membrane localization plays important roles in metabolism as well as asymmetric distributions of PI(4,5)P2 and phosphatidylinositol 3,4,5-trisphosphate in polarized cell membranes (25) .
In summary, we have elucidated the molecular basis of Par-3/PTEN interaction by the determination of the solution structures of Par-3 PDZ3 alone and in complex with the PTEN peptide. We demonstrated that the Par-3 PDZ3-mediated junctional membrane enrichment of PTEN is critical for epithelial cell polarization and for the enrichment of PI(4,5)P2 in junctional membranes. The data presented in this study provide a mechanistic connection between phosphoinositide signaling and the Par-3⅐Par-6⅐aPKC complex in the context of cell polarity regulation.
